BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Transgene: Third Quarter Marked by Progress in Clinical Development and Research

  Transgene, a biotech company that designs and develops viral-based immunotherapies, today announces its business update for the quarter ending September 30, 2017.

  October 19, 2017

   · 

  7 min read
• BioMidwest

  PolarityTE Lead Product, SkinTE, is Approved for Use by Multiple Medical Institutions

  Clinical application is expected in the fourth quarter of 2017, and data is planned to be released through multiple channels in the first half of 2018.

  October 19, 2017

   · 

  5 min read
• Biotech Bay

  Zogenix: High Seizure Frequency in Children With Dravet Syndrome Negatively Impacts Quality of Life, New International Caregiver Survey Finds

  The results suggest a need for more effective antiepileptic treatments.

  October 19, 2017

   · 

  5 min read
• MedDay To Participate In The 7th Joint ECTRIMS - ACTRIMS Meeting In Paris, France

  MedDay announces that it will be participating in the 7th Joint European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) -Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) meeting, to be held from 25-28 October 2017 in Paris, France.

  October 19, 2017

   · 

  5 min read
• The New Orleans BioInnovation Center Holds the Fifth-Annual Innovation Louisiana Nov. 5 - 10

  The New Orleans BioInnovation Center presents the fifth-annual Innovation Louisiana, their flagship event series held each fall, to educate biotech innovators and showcase groundbreaking research being done around the state.

  October 19, 2017

   · 

  3 min read
• The Board of Directors of Nexstim Plc Resolved on Amendments of the Stock Options 2016 and on a New Stock Option Plan for the CEO

  Nexstim’s Board of Directors resolved on May 25, 2016 to issue stock options to the key employees and consultants of the company and its subsidiaries.

  October 19, 2017

   · 

  6 min read
• Biotech Bay

  Anatara Lifesciences Investor Presentation This Week

  Anatara Lifesciences is pleased to release its latest institutional roadshow presentation and market update that will be delivered to investors this week by CEO - chairman, Dr Mel Bridges and Co-Founder and Chief Scientific Officer, Dr Tracey Mynott.

  October 19, 2017

   · 

  1 min read
• Drug Development

  Editas Medicine Demonstrates Dose-Dependent, In Vivo Editing With EDIT-101 in CEP290 Transgenic Mice

  Productive gene editing rates with EDIT-101 were stable over six months in transgenic mice.

  October 19, 2017

   · 

  5 min read
• FDA

  Nexus Pharmaceuticals Receives FDA Approval for Procainamide HCL Injection, USP

  Nexus Pharma announced today the immediate availability in the United States of Procainamide HCL Injection, USP.

  October 19, 2017

   · 

  1 min read
• Deals

  Konica Minolta and Innovation Network Corporation of Japan Close Acquisition of Ambry Genetics

  Konica Minolta and Innovation Network Corporation of Japan announced the close of their joint acquisition of Ambry Genetics Corporation on October 19, 2017 (JST).

  October 19, 2017

   · 

  3 min read